coronavirus
UK to trial use of #COVID-19 survivors' blood plasma for treatment
“NHS Blood and Transplant is preparing to collect COVID-19 convalescent plasma from people who have recovered from this illness,” a spokeswoman said. “We envisage that this will be initially used in trials as a possible treatment for COVID-19.”
“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival,” the blood service said.
“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible.”
People who have recovered from COVID-19 can register with the NHS if they are interested in donating plasma but they should not just turn up at blood donation centres.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Middle East3 days agoSecurity realignment inevitable in Middle East after Netanyahu-Trump's war
-
Transport3 days agoBetter enforcement of passenger rights: New EU agreement strengthens protection across all modes of transport
-
Uzbekistan4 days agoThe Third International Maqom Art Forum and the New Uzbekistan
-
Ukraine5 days ago'Ukraine does not need investment out of sympathy': Seyar Kurshutov on the rational case for early entry
